This paper examines the effects of data privacy regulation on R&D investment in the pharmaceutical and biotechnology sectors. In these industries, access to personal health data is essential for innovation, particularly in clinical research. Leveraging a firm-level panel of the world's top R&D...

This study investigates how neuromarketing practices intersect with consumer privacy regulation in California, with particular attention to the 2024 Senate Bill 1223 (SB 1223), which amends the CCPA/CPRA to explicitly define "neural data." By examining corporate strategies and regulatory...

This study addresses the challenge of governing privacy within data ecosystems by integrating architectural thinking (AT) into the discourse. Organizations are increasingly embarking on complex data-sharing initiatives, often encompassing personal data, raising heightened privacy concerns and...